You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Anti-CD25 Humanized monoclonal antibody used for immunosuppression in organ Transplant patient is: and explain in detail?
Basiliximab is an Anti-CD25 Antibody (IL-2 receptor antagonists used for immunosuppression in organ transplant patiennts. Monoclonal Antibodies as Immunosuppressive agents in Organ Transplantation: Anti-CD3- Muromonab-CD3 Anti-CD20-Rituximab Anti-CD25 (IL 2 receptor)- Basiliximab(Chimeric), Daclizumab(Humanized) Anti-CD52-Alemtuzumab Drug (Trade name) Target Monoclonal Antibody Type Mechanism Muromonab-CD3 (Ohoclone OKT3) Anti-CD3 Murine(Mouse) Monoclonal antibody Binds CD3 associated with the TCR, leading to initial activation and cytokine release, followed by blockade of function, lysis and T cell depletion Rituximab (Rituxan) Anti-CD20 Recombinant Chimeric Monoclonal antibody Binds to CD20 on B cells and causes depletion Basiliximab (Simulect) Anti-CD25 Recombinant Chimeric Monoclonal Antibody Binds to high-affinity chain of IL-2 Receptors (CD25) on activated T cells, causing depletion and preventing IL-2 mediated activation Daclizumab (Zenopax) Anti-CD25 Recombinant Humanized Monoclonal Antibody Similar to that of Basiliximab Alemtuzumab (Campath-1h) Anti-CD52 Recombinant Humanized Monoclonal Antibody Binds to CD52 expressed on most T and B cells, monocytes, macrophages, and NK cells, causing lysis and prolonged depletion Ref: KDT 7th edition Pgno: 878